[Serum lipoprotein profile in newly recognized arterial hypertension. The role of atherogenic lipoproteins in the pathogenesis of disease].
New examination approaches in biochemical analysis of lipoproteins can identify and quantify atherogenic plasma lipoproteins, including small dense LDL and characterise a lipoprotein spectrum as a non-atherogenic lipoprotein profile phenotype A, respectively as an atherogenic lipoprotein profile phenotype B. Identification of a non-aterogenic hypercholesterolemia (48%), atherogenic hypertriglyceridemia (93%), atherogenic normolipemia (13%) in patients with arterial hypertension and an atherogenic normolipemia in control group of healthy subjects (7%), is an essential contribution of this new laboratory diagnostics.
II. interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika. stanislavoravec@yahoo.com
S
S
Oravec
A
A
Dukát
P
P
Gavorník
M
M
Caprdna
M
M
Kucera
D050197:Atherosclerosis / Q000503:physiopathology; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000503:physiopathology; D006973:Hypertension / Q000097:blood* / Q000150:complications; D008074:Lipoproteins / Q000097:blood* / Q000502:physiology; D008297:Male; D008875:Middle Aged
D008074:Lipoproteins